|
|
Line 1: |
Line 1: |
| | | |
| ==Murin CXCL13 solution structure== | | ==Murin CXCL13 solution structure== |
- | <StructureSection load='5l7m' size='340' side='right'caption='[[5l7m]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='5l7m' size='340' side='right'caption='[[5l7m]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[5l7m]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L7M OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L7M FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5l7m]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L7M OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5L7M FirstGlance]. <br> |
- | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Cxcl13, Blc, Scyb13 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr> | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5l7m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l7m OCA], [https://pdbe.org/5l7m PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5l7m RCSB], [https://www.ebi.ac.uk/pdbsum/5l7m PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5l7m ProSAT]</span></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l7m FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l7m OCA], [http://pdbe.org/5l7m PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l7m RCSB], [http://www.ebi.ac.uk/pdbsum/5l7m PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l7m ProSAT]</span></td></tr> | + | |
| </table> | | </table> |
| == Function == | | == Function == |
- | [[http://www.uniprot.org/uniprot/CXL13_MOUSE CXL13_MOUSE]] Strongly chemotactic for B-lymphocytes, weakly for spleen monocytes and macrophages but no chemotactic activity for granulocytes. Binds to BLR1/CXCR5. May play a role in directing the migration of B-lymphocytes to follicles in secondary lymphoid organs. | + | [https://www.uniprot.org/uniprot/CXL13_MOUSE CXL13_MOUSE] Strongly chemotactic for B-lymphocytes, weakly for spleen monocytes and macrophages but no chemotactic activity for granulocytes. Binds to BLR1/CXCR5. May play a role in directing the migration of B-lymphocytes to follicles in secondary lymphoid organs. |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 20: |
Line 19: |
| | | |
| ==See Also== | | ==See Also== |
- | *[[C-X-C motif chemokine|C-X-C motif chemokine]] | + | *[[C-X-C motif chemokine 3D structures|C-X-C motif chemokine 3D structures]] |
| == References == | | == References == |
| <references/> | | <references/> |
Line 26: |
Line 25: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Lk3 transgenic mice]] | + | [[Category: Mus musculus]] |
- | [[Category: Lortat-Jacob, H]] | + | [[Category: Lortat-Jacob H]] |
- | [[Category: Monneau, Y R]] | + | [[Category: Monneau YR]] |
- | [[Category: Chemokine structure]]
| + | |
- | [[Category: Gag binding]]
| + | |
- | [[Category: N-terminal domain]]
| + | |
- | [[Category: Signaling protein]]
| + | |
| Structural highlights
Function
CXL13_MOUSE Strongly chemotactic for B-lymphocytes, weakly for spleen monocytes and macrophages but no chemotactic activity for granulocytes. Binds to BLR1/CXCR5. May play a role in directing the migration of B-lymphocytes to follicles in secondary lymphoid organs.
Publication Abstract from PubMed
Chemokines promote directional cell migration through binding to G-protein-coupled receptors, and as such are involved in a large array of developmental, homeostatic and pathological processes. They also interact with heparan sulfate (HS), the functional consequences of which depend on the respective location of the receptor- and the HS-binding sites, a detail that remains elusive for most chemokines. Here, to set up a biochemical framework to investigate how HS can regulate CXCL13 activity, we solved the solution structure of CXCL13. We showed that it comprises an unusually long and disordered C-terminal domain, appended to a classical chemokine-like structure. Using three independent experimental approaches, we found that it displays a unique association mode to HS, involving two clusters located in the alpha-helix and the C-terminal domain. Computational approaches were used to analyse the HS sequences preferentially recognized by the protein and gain atomic-level understanding of the CXCL13 dimerization induced upon HS binding. Starting with four sets of 254 HS tetrasaccharides, we identified 25 sequences that bind to CXCL13 monomer, among which a single one bound to CXCL13 dimer with high consistency. Importantly, we found that CXCL13 can be functionally presented to its receptor in a HS-bound form, suggesting that it can promote adhesion-dependent cell migration. Consistently, we designed CXCL13 mutations that preclude interaction with HS without affecting CXCR5-dependent cell signalling, opening the possibility to unambiguously demonstrate the role of HS in the biological function of this chemokine.
Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.,Monneau YR, Luo L, Sankaranarayanan NV, Nagarajan B, Vives RR, Baleux F, Desai UR, Arenzana-Seidedos F, Lortat-Jacob H Open Biol. 2017 Oct;7(10). pii: rsob.170133. doi: 10.1098/rsob.170133. PMID:29070611[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Monneau YR, Luo L, Sankaranarayanan NV, Nagarajan B, Vives RR, Baleux F, Desai UR, Arenzana-Seidedos F, Lortat-Jacob H. Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains. Open Biol. 2017 Oct;7(10). pii: rsob.170133. doi: 10.1098/rsob.170133. PMID:29070611 doi:http://dx.doi.org/10.1098/rsob.170133
|